1-(([1, 1',-BIPHENYL]-2-YL)SULFONYL)-4-FLUORO-N-(3-(METHYLSULFONYL)ALLYL)PIPERIDINE-4-CARBOXAMIDE DERIVATIVES AS RAS-PI3K MODULATORS FOR THE TREATMENT OF E.G. CANCER

出願人

Vividion Therapeutics, Inc.

発明者

TAMIYA, Junko; HORNING, Benjamin; BEDKE, Karl; BERRY, Cynthia; PAN, Chung-Mao; ONDOZABAL, Hideki Miyatake; COOK, Brian

出願日

Feb 26, 2024

公開日

Jan 6, 2026